Selenium induces cholinergic motor neuron degeneration in Caenorhabditis elegans

NeuroToxicology

Volumn 33, Issue 5, 2012, Pages 1021-1032

  Estevez, Annette O ^a   Mueller, Catherine L ^a   Morgan, Kathleen L ^b   Szewczyk, Nathaniel J ^c   Teece, Luke ^a   Miranda Vizuete, Antonio ^d   Estevez, Miguel ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Cholinergic; Glutathione; Neurodegeneration; Oxidative stress; Selenium

Indexed keywords

CHOLINERGIC RECEPTOR; GLUTAREDOXIN 21; GLUTATHIONE; OXIDOREDUCTASE; SELENIUM; UNCLASSIFIED DRUG; VESICULAR ACETYLCHOLINE TRANSPORTER;

ARTICLE; CAENORHABDITIS ELEGANS; CHOLINERGIC NERVE CELL; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; EGG LAYING; EXPOSURE; GENE MUTATION; MOTONEURON; MOTOR DYSFUNCTION; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ACTINS; ADJUVANTS, IMMUNOLOGIC; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIOXIDANTS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CELL COUNT; CHOLINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; GALACTOSIDES; GLUTATHIONE; GREEN FLUORESCENT PROTEINS; LEVAMISOLE; MOTOR NEURONS; MOVEMENT; MUSCLE PROTEINS; MUSCLES; MUTATION; NERVE DEGENERATION; PARALYSIS; RECEPTORS, CHOLINERGIC; REPRODUCTION; SELENIUM; SIGNAL TRANSDUCTION; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

ANIMALIA; CAENORHABDITIS ELEGANS; VERTEBRATA;

EID: 84867231181     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.04.019     Document Type: Article

References (66)

1. Alfonso A., Grundahl K., Duerr J.S., Han H.P., Rand J.B. The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter. Science 1993, 261(5121):617-619.
2. Bany I.A., Dong M.-Q., Koelle M.R. Genetic and cellular basis for acetylcholine inhibition of Caenorhabditis elegans egg-laying behavior. J Neurosci 2003, 23(22):8060-8069.
3. Bellinger F.P., Raman A.V., Reeves M.A., Berry M.J. Regulation and function of selenoproteins in human disease. Biochem J 2009, 422(1):11-22.
4. Bonilla-Ramirez L., Jimenez-Del-Rio M., Velez-Pardo C. Acute and chronic metal exposure impairs locomotion activity in Drosophila melanogaster: a model to study Parkinsonism. Biometals 2011, 24(6):1045-1057.
5. Boulin T., Gielen M., Richmond J.E., Williams D.C., Paoletti P., Bessereau J.L. Eight genes are required for functional reconstitution of the Caenorhabditis elegans levamisole-sensitive acetylcholine receptor. Proc Natl Acad Sci U S A 2008, 105(47):18590-18595.
6. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77(1):71-94.
7. Cao P., Yuan Y., Pehek E.A., Moise A.R., Huang Y., Palczewski K., et al. Alpha-synuclein disrupted dopamine homeostasis leads to dopaminergic neuron degeneration in Caenorhabditis elegans. PLoS One 2010, 5(2):e9312.
8. Carre-Pierrat M., Baillie D., Johnsen R., Hyde R., Hart A., Granger L., et al. Characterization of the Caenorhabditis elegans G protein-coupled serotonin receptors. Invert Neurosci 2006, 6(4):189-205.
9. Chesselet M.F., Richter F. Modelling of Parkinson's disease in mice. Lancet Neurol 2011, 10(12):1108-1118.
10. Corbett A.J., Griggs R.C., Moxley R.T. Skeletal muscle catabolism in amyotrophic lateral sclerosis and chronic spinal muscular atrophy. Neurology 1982, 32(5):550-552.
11. de Bono M., Maricq A.V. Neuronal substrates of complex behaviors in C. elegans. Annu Rev Neurosci 2005, 28:451-501.
12. Desai C., Garriga G., McIntire S.L., Horvitz H.R. A genetic pathway for the development of the Caenorhabditis elegans HSN motor neurons. Nature 1988, 336(6200):638-646.
13. Dimitriadi M., Hart A.C. Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans. Neurobiol Dis 2010, 40(1):4-11.
14. Dittman J.S., Kaplan J.M. Behavioral impact of neurotransmitter-activated G-protein-coupled receptors: muscarinic and GABAB receptors regulate Caenorhabditis elegans locomotion. J Neurosci 2008, 28(28):7104-7112.
15. Duerr J.S., Han H.P., Fields S.D., Rand J.B. Identification of major classes of cholinergic neurons in the nematode Caenorhabditis elegans. J Comp Neurol 2008, 506(3):398-408.
16. Estevez M., Estevez A.O., Cowie R.H., Gardner K.L. The voltage-gated calcium channel UNC-2 is involved in stress-mediated regulation of tryptophan hydroxylase. J Neurochem 2004, 88(1):102-113.
17. Estes P.S., Boehringer A., Zwick R., Tang J.E., Grigsby B., Zarnescu D.C. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet 2011, 20(12):2308-2321.
18. Fairweather-Tait S.J., Bao Y., Broadley M.R., Collings R., Ford D., Hesketh J.E., et al. Selenium in human health and disease. Antioxid Redox Signal 2011, 14(7):1337-1383.
19. Ferri A., Fiorenzo P., Nencini M., Cozzolino M., Pesaresi M.G., Valle C., et al. Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity. Hum Mol Genet 2010, 19(22):4529-4542.
20. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004, 185(2):232-240.
21. Fostel J.L., Benner Coste L., Jacobson L.A. Degradation of transgene-coded and endogenous proteins in the muscles of Caenorhabditis elegans. Biochem Biophys Res Commun 2003, 312(1):173-177.
22. Hobson R.J., Hapiak V.M., Xiao H., Buehrer K.L., Komuniecki P.R., Komuniecki R.W. SER-7, a Caenorhabditis elegans 5-HT7-like receptor, is essential for the 5-HT stimulation of pharyngeal pumping and egg laying. Genetics 2006, 172(1):159-169.
23. Hosono R., Kamiya Y. Additional genes which result in an elevation of acetylcholine levels by mutations in Caenorhabditis elegans. Neurosci Lett 1991, 128(2):243-244.
24. Hung W., Hwang C., Po M.D., Zhen M. Neuronal polarity is regulated by a direct interaction between a scaffolding protein, Neurabin, and a presynaptic SAD-1 kinase in Caenorhabditis elegans. Development 2007, 134(2):237-249.
25. Ishrat T., Parveen K., Khan M.M., Khuwaja G., Khan M.B., Yousuf S., et al. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 2009, 1281:117-127.
26. Kanning K.C., Kaplan A., Henderson C.E. Motor neuron diversity in development and disease. Annu Rev Neurosci 2010, 33:409-440.
27. Koller L.D., Exon J.H. The two faces of selenium deficiency and toxicity are similar in animals and man. Can J Vet Res 1986, 50:297-306.
28. Lee Y.-S., Park Y.S., Nam S., Suh S.J., Lee J., Kaang B.K., et al. Characterization of GAR-2, a novel G protein-linked acetylcholine receptor from Caenorhabditis elegans. J Neurochem 2000, 75:1800-1809.
29. Lewis J.A., Wu C.H., Levine J.H., Berg H. Levamisole-resistant mutants of the nematode Caenorhabditis elegans appear to lack pharmacological acetylcholine receptors. Neuroscience 1980, 5(6):967-989.
30. Li W.H., Hsu F.L., Liu J.T., Liao V.H. The ameliorative and toxic effects of selenite on Caenorhabditis elegans. Food Chem Toxicol 2011, 49(4):812-819.
31. Lin-Shiau S.Y., Liu S.H., Fu W.M. Neuromuscular actions of sodium selenite on chick biventercervicis nerve-muscle preparation. Neuropharmacology 1990, 29(5):493-501.
32. Mahoney T.R., Luo S., Nonet M.L. Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay. Nat Protoc 2006, 1(4):1772-1777.
33. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., et al. Bates GP Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87(3):493-506.
34. Martin R.J., Verma S., Levandoski M., Clark C.L., Qian H., Stewart M., et al. Drug resistance and neurotransmitter receptors of nematodes: recent studies on the mode of action of levamisole. Parasitology 2005, 131:S71-S84.
35. McIntire S.L., Jorgensen E., Kaplan J., Horvitz H.R. The GABAergic nervous system of Caenorhabditis elegans. Nature 1993, 364(6435):337-341.
36. Miller K.G., Alfonso A., Nguyen M., Crowell J.A., Johnson C.D., Rand J.B. A genetic selection for Caenorhabditis elegans synaptic transmission mutants. Proc Natl Acad Sci U S A 1996, 93:12593-12598.
37. Misra S., Hamilton C., Niyogi S. Induction of oxidative stress by selenomethionine in isolated hepatocytes of rainbow trout (Oncorhynchus mykiss). Toxicol In Vitro 2012, 10.1016/j.tiv.2012.02.001.
38. Moerman G.D., Fire A. Muscle: structure, function, and development. C. elegans II 1997, 418. Cold Spring Harbor, New York. D.L. Riddle, T. Blumenthal, B.J. Meyer, J.R. Priess (Eds.).
39. Morgan K.L., Estevez A.O., Mueller C.L., Cacho-Valadez B., Miranda-Vizuete A., Szewczyk N.J., et al. The glutaredoxin GLRX-21 functions to prevent selenium-induced oxidative stress in Caenorhabditis elegans. Toxicol Sci 2010, 118(2):530-543.
40. Morley J.F., Brignull H.R., Weyers J.J., Morimoto R.I. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A 2002, 99(16):10417-10422.
41. Nathues H., Boehne I., grosse Beilage T., Gerhauser I., Hewicker-Trautwein M., Wolf P., et al. Peracute selenium toxicosis followed by sudden death in growing and finishing pigs. Can Vet J 2010, 51(5):515-518.
42. Nguyen M., Alfonso A., Johnson C.D., Rand J.B. Caenorhabditis elegans mutants resistant to inhibitors of acetylcholinesterase. Genetics 1995, 140(2):527-535.
43. Nonet M.L., Saifee O., Zhao H., Rand J.B., Wei L. Synaptic transmission deficits in Caenorhabditis elegans synaptobrevin mutants. J Neurosci 1998, 18(1):70-80.
44. Panter K.E., Hartley W.J., James L.F., Mayland H.F., Stegelmeier B.L., Kechele P.O. Comparative toxicity of selenium from seleno-dl-methionine, sodium selenate, and Astragalus bisculcatus in pigs. Fundam Appl Toxicol 1996, 32:217-223.
45. Rand J.B., Russell R.L. Choline acetyltransferase-deficient mutants of the nematode Caenorhabditis elegans. Genetics 1984, 106(2):227-248.
46. Rederstorff M., Krol A., Lescure A. Understanding the importance of selenium and selenoproteins in muscle function. Cell Mol Life Sci 2006, 63(1):52-59.
47. Richmond J.E., Jorgensen E.M. One G.A.B.A two acetylcholine receptors function at the C. elegans neuromuscular junction. Nat Neurosci 1999, 2:791-797.
48. Sandoval G.M., Duerr J.S., Hodgkin J., Rand J.B., Ruvkun G. A genetic interaction between the vesicular acetylcholine transporter VAChT/UNC-17 and synaptobrevin/SNB-1 in C. elegans. Nat Neurosci 2006, 9(5):599-601.
49. Schweizer U., Bräuer A.U., Köhrle J., Nitsch R., Savaskan N.E. Selenium and brain function: a poorly recognized liaison. Brain Res Brain Res Rev 2004, 45(3):164-178.
50. Shephard F., Adenle A.A., Jacobson L.A., Szewczyk N.J. Identification and functional clustering of genes regulating muscle protein degradation from amongst the known C. elegans muscle mutants. PLoS One 2011, 6(9):e24686.
51. Shyn S.I., Kerr R., Schafer W.R. Serotonin and Go modulate functional states of neurons and muscles controlling C. elegans egg-laying behavior. Curr Biol 2003, 13:1910-1915.
52. Silverman G.A., Luke C.J., Bhatia S.R., Long O.S., Vetica A.C., Perlmutter D.H., et al. Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans. Pediatr Res 2009, 65(1):10-18.
53. Spiller H.A., Pfiefer E. Two fatal cases of selenium toxicity. Forensic Sci Int 2007, 171(1):67-72.
54. Szewczyk N.J., Hartman J.J., Barmada S.J., Jacobson L.A. Genetic defects in acetylcholine signaling promote protein degradation in muscle cells of Caenorhabditis elegans. J Cell Sci 2000, 113(Pt 11):2003-2010.
55. Takács-Vellai K., Bayci A., Vellai T. Autophagy in neuronal cell loss: a road to death. Bioessays 2006, 28(11):1126-1131.
56. Tamura T., Sone M., Iwatsubo T., Tagawa K., Wanker E.E., Okazawa H. Ku70 alleviates neurodegeneration in Drosophila models of Huntington's disease. PLoS One 2011, 6(11):e27408.
57. Touroutine D., Fox R.M., Von Stetina S.E., Burdina A., Miller D.M., Richmond J.E. acr-16 encodes an essential subunit of the levamisole-resistant nicotinic receptor at the Caenorhabditis elegans neuromuscular junction. J Biol Chem 2005, 280:27013-27021.
58. Trent C., Tsuing N., Horvitz H.R. Egg-laying defective mutants of the nematode Caenorhabditis elegans. Genetics 1983, 104(4):619-647.
59. van Eersel J., Ke Y.D., Liu X., Delerue F., Kril J.J., Götz J., et al. Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. Proc Natl Acad Sci U S A 2010, 107(31):13888-13893.
60. Vinceti M., Bonvicini F., Bergomi M., Malagoli C. Possible involvement of overexposure to environmental selenium in the etiology of amyotrophic lateral sclerosis: a short review. Ann Ist Super Sanita 2010, 46(3):279-283.
61. Wallenberg M., Olm E., Hebert C., Björnstedt M., Fernandes A.P. Selenium compounds are substrates for glutaredoxins: a novel pathway for selenium metabolism and a potential mechanism for selenium-mediated cytotoxicity. Biochem J 2010, 429(1):85-93.
62. Wang J., Farr G.W., Hall D.H., Li F., Furtak K., Dreier L., et al. An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet 2009, 5(1):e1000350.
63. White J.G., Southgate E., Thomson J.N., Brenner S. The structure of the nervous system of the nematode Caenorhabditis elegans. Philos Trans R Soc Lond B Biol Sci 1986, 314:1-340.
64. Wood-Allum C.A., Barber S.C., Kirby J., Heath P., Holden H., Mead R., et al. Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen. Brain 2006, 129(Pt 7):1693-1709.
65. Zafar K.S., Siddiqui A., Sayeed I., Ahmad M., Salim S., Islam F. Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J Neurochem 2003, 84(3):438-446.
66. Zahn T.R., Macmorris M.A., Dong W., Day R., Hutton J.C. IDA-1, a Caenorhabditis elegans homolog of the diabetic autoantigensIA-2 and phogrin, is expressed in peptidergic neurons in the worm. J Comp Neurol 2001, 429(1):127-143.